About us » DDA Membership » Midazolam Endorsing Guidance
By Ailsa Colquhoun
From 1 December, 2011, where the contractor has provided the prescribed quantity of Midazolam 10mg/ml oral solution in containers with an integral means of administration, these prescriptions will be reimbursed as multiples of the 5ml basic price listed in Part VIIIB of the Drug Tariff.
To ensure accurate payment, contractors must clearly endorse where they have supplied containers with an integral means of administration e.g. the quantity dispensed over pack size (20ml/5ml) or as 4x5ml.
Where the prescription is not endorsed to indicate that the contractor has supplied a container with an integral means of administration, payment will be based on the existing arrangements laid out in Part VIIIB - the minimum volume (5ml) plus the price/ml for any volume dispensed thereafter.
Dr Philip Koopowitz points out the pitfalls of getting the endorsing wrong:
So if you supply 10ml of Midazolam solution, you will be re-imbursed for 5ml + 5 x 1ml extra ie. £97.51 + 5 x 0.87 = £101.86, if it is not endorsed correctly.
But if you had been supplied 2 x 5ml by the supplier, you could potentially be charged 2 x £97.51 =£195.02.
So endorse in multiples of 5ml.